Compare JVA & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JVA | IRIX |
|---|---|---|
| Founded | 1971 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 18.2M |
| IPO Year | 1997 | 1996 |
| Metric | JVA | IRIX |
|---|---|---|
| Price | $4.35 | $1.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 48.7K | ★ 51.8K |
| Earning Date | 06-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $90,655,294.00 | $41,593,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $6.66 |
| P/E Ratio | $14.79 | ★ N/A |
| Revenue Growth | ★ 17.54 | N/A |
| 52 Week Low | $2.93 | $0.87 |
| 52 Week High | $5.62 | $1.65 |
| Indicator | JVA | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 41.73 |
| Support Level | $4.04 | $0.95 |
| Resistance Level | $4.79 | $1.18 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 30.67 | 7.14 |
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.